Gfg Capital, LLC Pfizer Inc Transaction History

Gfg Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$25.26 - $29.6 $55,572 - $65,120	2,200 Added 21.42%	12,469 $348,000
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $265,864 - $305,297	10,269 New	10,269 $284,000
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $7.52 Million - $8.8 Million	-234,487 Reduced 96.99%	7,289 $241,000
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $7.51 Million - $8.78 Million	234,167 Added 3077.5%	241,776 $8.02 Million
Q2 2023 Jul 28, 2023	BUY	$36.12 - $41.79 $274,837 - $317,980	7,609 New	7,609 $279,000
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $275,506 - $341,387	-6,022 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$41.32 - $61.25 $13,800 - $20,457	334 Added 5.87%	6,022 $356,000
Q2 2021 Jul 12, 2021	SELL	$35.91 - $40.68 $5,242 - $5,939	-146 Reduced 2.5%	5,688 $223,000
Q1 2021 Apr 28, 2021	SELL	$33.49 - $37.77 $2,746 - $3,097	-82 Reduced 1.39%	5,834 $211,000
Q4 2020 Jan 28, 2021	BUY	$33.47 - $42.56 $198,008 - $251,784	5,916 New	5,916 $218,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Gfg Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Gfg Capital, LLC with notifications on news.